Know Cancer

or
forgot password

Virtual Colonoscopy: Comparison of Reduced Laxative Virtual Colonoscopy Regimens With Standard Preparation on Patient Experience and Compliance - a Questionnaire Based Study


Phase 4
18 Years
N/A
Not Enrolling
Both
Colorectal Cancer

Thank you

Trial Information

Virtual Colonoscopy: Comparison of Reduced Laxative Virtual Colonoscopy Regimens With Standard Preparation on Patient Experience and Compliance - a Questionnaire Based Study


Bowel cleansing with high dose laxative is the standard bowel preparation prior to whole
colon investigations but such regimens are associated with considerable patient discomfort
and inconvenience, potentially affecting compliance rates [1-3].

Unlike existing whole colon investigations (conventional colonoscopy and barium enema),
reduced laxative regimens can be successfully used with VC, with the aim of improving
patient experience, whilst maintaining diagnostic accuracy. These regimens utilize faecal
tagging; a method of labeling residual faeces and fluid with radiodense liquids, such as
iodine or barium based fluids, which are taken orally by the patient. Once faecal residue
and fluid is labeled in this way, it can easily be discriminated from true pathology (which
remains 'untagged').

We are proposing to compare different bowel preparation regimens, and ascertain patient
experience of the different regimes, while monitoring diagnostic accuracy of the 2 different
regiments.


Inclusion Criteria:



- patients with symptoms attributable to colorectal cancer

Exclusion Criteria:

- patients with known colorectal cancer referred for staging VC

- patients who take laxatives regularly or with previous inadequate colonic examination
due to excessive faecal residue

- patients deemed too frail to undergo full bowel preparation

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Outcome Measure:

Versus standard bowel preparation

Outcome Time Frame:

1 day (while on regimen + effectivness analysis time)

Principal Investigator

David Burling

Investigator Role:

Principal Investigator

Investigator Affiliation:

St Mark's Hospital, North West London Hospitals NHS Trust

Authority:

United Kingdom: Medicines and Healthcare Products Regulatory Agency

Study ID:

07.senna.SMH

NCT ID:

NCT00460837

Start Date:

November 2007

Completion Date:

March 2009

Related Keywords:

  • Colorectal Cancer
  • colorectal cancer
  • bowel preparation regimen
  • patients with symptoms attributable to colorectal cancer
  • Colorectal Neoplasms

Name

Location